Patent 7361764 was granted and assigned to SGX Pharmaceuticals on April, 2008 by the United States Patent and Trademark Office.
The present invention provides novel pyrrolo-pyridine kinase modulators and methods of using the novel pyrrolo-pyridine kinase modulators to treat diseases mediated by kinase activity.